SCI Pharmtech, Inc. (TPE:4119)
Taiwan
· Delayed Price · Currency is TWD 48.20
+0.70 (1.47%)
Apr 29, 2026, 1:30 PM CST
SCI Pharmtech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 5,754 | 5,820 | 10,827 | 11,568 | 9,300 | 8,012 | Upgrade
|
| Market Cap Growth | -37.95% | -46.25% | -6.40% | 24.39% | 16.07% | 20.00% | Upgrade
|
| Enterprise Value | 6,667 | 6,694 | 11,388 | 12,218 | 9,171 | 6,991 | Upgrade
|
| Last Close Price | 48.15 | 48.70 | 88.50 | 93.25 | 82.01 | 70.66 | Upgrade
|
| PE Ratio | 53.59 | 54.20 | 20.25 | 39.25 | 30.12 | 143.85 | Upgrade
|
| Forward PE | - | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | Upgrade
|
| PS Ratio | 4.28 | 4.33 | 7.11 | 9.61 | 10.34 | 9.27 | Upgrade
|
| PB Ratio | 1.07 | 1.08 | 1.98 | 2.27 | 2.56 | 2.41 | Upgrade
|
| P/TBV Ratio | 1.07 | 1.09 | 1.99 | 2.29 | 2.60 | 2.46 | Upgrade
|
| P/OCF Ratio | 26.12 | 26.42 | 12.58 | 53.62 | 31.36 | 28.59 | Upgrade
|
| EV/Sales Ratio | 4.96 | 4.98 | 7.47 | 10.15 | 10.19 | 8.09 | Upgrade
|
| EV/EBITDA Ratio | 18.44 | 16.63 | 26.50 | 40.23 | 44.10 | 51.56 | Upgrade
|
| EV/EBIT Ratio | 61.38 | 43.12 | 57.43 | 76.22 | 77.09 | 94.91 | Upgrade
|
| Debt / Equity Ratio | 0.18 | 0.18 | 0.18 | 0.20 | 0.15 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 2.42 | 2.42 | 2.29 | 3.41 | 2.60 | 0.02 | Upgrade
|
| Net Debt / Equity Ratio | 0.17 | 0.17 | 0.05 | 0.00 | 0.08 | -0.21 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.27 | 2.27 | 0.69 | 0.04 | 1.35 | -5.09 | Upgrade
|
| Net Debt / FCF Ratio | -2.34 | -2.34 | -3.46 | -0.01 | -0.32 | 1.41 | Upgrade
|
| Asset Turnover | 0.19 | 0.19 | 0.22 | 0.21 | 0.20 | 0.20 | Upgrade
|
| Inventory Turnover | 1.47 | 1.47 | 1.94 | 1.64 | 1.51 | 1.94 | Upgrade
|
| Quick Ratio | 0.31 | 0.31 | 0.97 | 2.35 | 0.61 | 1.39 | Upgrade
|
| Current Ratio | 1.05 | 1.05 | 1.64 | 3.43 | 1.35 | 1.87 | Upgrade
|
| Return on Equity (ROE) | 1.98% | 1.98% | 10.11% | 6.75% | 8.89% | 1.68% | Upgrade
|
| Return on Assets (ROA) | 1.38% | 1.38% | 1.78% | 1.72% | 1.63% | 1.05% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.47% | 2.57% | 3.01% | 2.88% | 2.90% | 2.35% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.70% | 2.70% | 3.20% | 2.60% | 2.80% | 2.10% | Upgrade
|
| Earnings Yield | 1.87% | 1.85% | 4.94% | 2.55% | 3.32% | 0.69% | Upgrade
|
| FCF Yield | -6.77% | -6.69% | -0.80% | -7.03% | -9.37% | -6.13% | Upgrade
|
| Dividend Yield | 1.58% | 1.54% | 1.70% | 1.34% | 0.27% | - | Upgrade
|
| Payout Ratio | 166.95% | 166.95% | 27.94% | 8.09% | - | 71.36% | Upgrade
|
| Buyback Yield / Dilution | 0.13% | 0.13% | -9.44% | -1.87% | -0.08% | 0.49% | Upgrade
|
| Total Shareholder Return | 1.70% | 1.67% | -7.74% | -0.53% | 0.19% | 0.49% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.